Evidence map›Paper›PMID 28717907›Full record

ArticleWorld journal of surgery2017

Elevated Lactate is Independently Associated with Adverse Outcomes Following Hepatectomy.

Madeline Lemke, Paul J Karanicolas, Rogeh Habashi, Ramy Behman, Natalie G Coburn, Sherif S Hanna, Calvin H L Law, Julie Hallet

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Post-hepatectomy Lactate: Should We Add More?World journal of surgery · 2018
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Madeline LemkeInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Paul J KaranicolasInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Rogeh HabashiDivision of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, T2-63, Toronto, ON, M4N 3M5, Canada.
Ramy BehmanInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Natalie G CoburnInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Sherif S HannaDivision of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, T2-63, Toronto, ON, M4N 3M5, Canada.
Calvin H L LawInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Julie HalletDivision of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, T2-63, Toronto, ON, M4N 3M5, Canada. julie.hallet@sunnybrook.ca.
Health Sciences Centre · CAUniversity of Toronto · CASunnybrook Health Science Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArterial lactate is frequently monitored to indicate tissue hypoxia and direct therapy. We sought to determine whether early post-hepatectomy lactate (PHL) is associated with adverse outcomes and define factors associated with PHL.

methodsHepatectomy patients at a single institution from 2003 to 2012 with PHL available were included. Univariable and multivariable analyses examined factors associated with PHL and the relationship between PHL and 30-day major morbidity (Clavien grade III-V), 90-day mortality, and length of stay (LOS).

resultsOf 749 hepatectomies, 490 were included of whom 71.4% had elevated PHL (≥2 mmol/L). Cirrhosis (coefficient 0.31, p = 0.039), Charlson comorbidity index (coefficient 0.05, p < 0.001), major resections (coefficient 0.34, p < 0.001), procedure time (coefficient 0.08, p < 0.001), and blood loss (coefficient 0.11, p < 0.001) were associated with PHL. As lactate increased from <2 to ≥6 mmol/L, morbidity rose from 11.6 to 40.6%, and mortality from 0.7 to 22.7%. PHL was independently associated with 90-day mortality (OR 1.52 p < 0.001) and 30-day morbidity (OR 1.19, p = 0.002), but not LOS (rate ratio 1.03, p = 0.071).

conclusionPatients with elevated PHL in the initial postoperative period should be carefully monitored due to increased risk of major morbidity and mortality. Further research on the impact of lactate-directed fluid therapy is warranted.

Indexed as

AgedBlood Loss, SurgicalFemaleHepatectomyHumansLactic AcidLength of StayMaleMiddle AgedOperative TimePostoperative ComplicationsPostoperative PeriodLactic Acid

Identifiers

PMID28717907
OpenAlexW2736256625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.